Li, Yamin
Li, Jia
Zhu, Zhaohua
Cao, Peihua
Han, Weiyu
Ruan, Guangfeng
Fan, Tianxiang
Hunter, David J.
Ding, Changhai http://orcid.org/0000-0002-9479-730X
Funding for this research was provided by:
National Natural Science Foundation of China (81773532)
Article History
Received: 27 February 2021
Revised: 3 June 2021
Accepted: 30 June 2021
First Online: 29 July 2021
Declarations
:
: The scientific guarantor of this publication is Changhai Ding, M.D. (Clinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China).
: The authors of this manuscript declare relationships with the following companies: DJH provides consulting advice to Pfizer, Lilly, TLC bio, Merck Serono.
: No complex statistical methods were necessary for this paper.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained.
: • prospective• nested case-control study• multicenter study